Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.
Researchers evaluated perioperative and postdischarge factors associated with opioid refill prescriptions during the first 90 days after inpatient otolaryngology–head and neck surgery.
Deep learning analysis of pediatric brain MRIs identifies links between upper airway size, cognition, and regional gray matter volumes, suggesting airway measurements may aid in assessing neurocognitive risk in sleep-disordered breathing.
Researchers report significant improvements in breath odor and oral health after four weeks using a natural essential oil rinse in patients with obesity and periodontitis.